PDS Biotechnology (PDSB) Insider Trading & Ownership → Buy this small stock before coming AI Tidal Wave (From Chaikin Analytics) (Ad) Free PDSB Stock Alerts $3.49 -0.04 (-1.13%) (As of 05/17/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media PDS Biotechnology (NASDAQ:PDSB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.00%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$226,067.50Number OfInsiders Selling(Last 3 Years)0 Get PDSB Insider Trade Alerts Want to know when executives and insiders are buying or selling PDS Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PDSB Insider Buying and Selling by Quarter Ad The Freeport SocietyNext President (Not Trump. Not Biden.)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.Click here to see why it will be ______ _________. PDS Biotechnology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/13/2021Matthew C HillCFOBuy2,900$8.99$26,071.00 6/15/2021Steve C GloverDirectorBuy5,882$8.50$49,997.00 6/15/2021Voorhees Seth VanCFOBuy17,647$8.50$149,999.50 (Data available from 1/1/2013 forward) PDSB Insider Trading Activity - Frequently Asked Questions Who is on PDS Biotechnology's Insider Roster? The list of insiders at PDS Biotechnology includes Matthew C Hill, Steve C Glover, and Voorhees Seth Van. Learn more on insiders at PDSB. What percentage of PDS Biotechnology stock is owned by insiders? 10.00% of PDS Biotechnology stock is owned by insiders. Learn more on PDSB's insider holdings. More Insider Trading Tools from MarketBeat Related Companies: Karyopharm Therapeutics Insider Ownership Context Therapeutics Insider Ownership OptiNose Insider Ownership Amylyx Pharmaceuticals Insider Ownership Cartesian Therapeutics Insider Ownership Nuvectis Pharma Insider Ownership Seres Therapeutics Insider Ownership Regulus Therapeutics Insider Ownership Vistagen Therapeutics Insider Ownership DiaMedica Therapeutics Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:PDSB) was last updated on 5/19/2024 by MarketBeat.com Staff From Our Partners[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaUrgent Nvidia WarningAltimetryForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMost important medical advance in 100 yearsThe Oxford Club41 banks launch ‘crypto dollar’Stansberry ResearchHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.